Stay updated with breaking news from Anixa Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $12.00 price objective on the stock. HC Wainwright also issued estimates for Anixa Biosciences’ FY2025 earnings at ($0.40) EPS. Anixa Biosciences Price Performance […]
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
A new vaccine hopes to protect against one of the more deadly forms of the cancer, and an Orlando woman was the first to take it! FOX 35 News introduced you to Jenni Davis back in April.
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Anixa Biosciences, Inc. (NASDAQ:ANIX – Free Report) – Investment analysts at Chardan Capital issued their FY2023 earnings estimates for Anixa Biosciences in a research note issued to investors on Monday, July 10th. Chardan Capital analyst M. Barcus expects that the company will post earnings of ($0.45) per share for the year. Chardan Capital has a […]